It was reported that the interaction between nucleolin and TopIIA was essential in blocking DNA damage and cellular apoptosis and abrogation of nucleolin-sensitized DLBCL cells to TopIIA-targeting agents.139. The gene discussed is NUCLEOLIN; the disease is diffuse large B-cell lymphoma.